Malin Corporation Plc
MLC | IR
Overview
Corporate Details
- ISIN(s):
- IE00BVGC3741
- LEI:
- 635400JG4YSDU5U1YU17
- Country:
- Ireland
- Address:
- The Lennox Building, D02 FK02 Dublin
- Website:
- http://malinplc.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Malin invests in and supports highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders. Our purpose is to create shareholder value through the application of long-term capital and strategic support to our investee companies to enable them to reach their value potential. Vision: To deliver significant returns for our shareholders and transformative outcomes for patients by investing in and supporting highly innovative life sciences companies
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-28 11:45 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 14.7 KB | |
| 2025-03-13 13:45 |
Takeover Announcement Report
Result of AGM & EGM
|
English | 35.3 KB | |
| 2025-02-19 08:00 |
Takeover Announcement Report
2024 Full Year Results & Notice of AGM
|
English | 28.7 KB | |
| 2025-02-19 08:00 |
Takeover Announcement Report
Proposed Tender Offer
|
English | 52.7 KB | |
| 2025-02-05 08:00 |
Takeover Announcement Report
Update on Return of Capital to Shareholders
|
English | 11.6 KB | |
| 2025-01-08 08:30 |
Takeover Announcement Report
Update re Poseida Transaction
|
English | 8.7 KB | |
| 2024-11-26 08:00 |
Takeover Announcement Report
Poseida to be Acquired and Update on Tender Offer
|
English | 13.2 KB | |
| 2024-11-12 08:00 |
Takeover Announcement Report
Proposed Tender Offer
|
English | 54.2 KB | |
| 2024-11-04 08:00 |
Share Issue/Capital Change
Block listing Interim Review
|
English | 13.4 KB | |
| 2024-09-26 16:45 |
Declaration of Voting Results & Voting Rights Announcements
Result of EGM
|
English | 10.8 KB | |
| 2024-08-27 08:00 |
Takeover Announcement Report
2024 Interim Report
|
English | 25.2 KB | |
| 2024-08-20 08:00 |
Earnings Release
Notice of 2024 Interim Results
|
English | 9.5 KB | |
| 2024-07-23 17:30 |
Takeover Announcement Report
Business Updates
|
English | 31.3 KB | |
| 2024-07-10 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 9.4 KB | |
| 2024-05-03 18:30 |
Regulatory News Service
Block listing Interim Review
|
English | 13.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Dermapharm Holding SE | Germany | DMP | |
|
Dicot Pharma AB | Sweden | DICOTBT | |
|
EARNZ PLC | United Kingdom | EARN | |
|
Eevia Health Plc | Finland | EEVIA | |
|
Egetis Therapeutics | Sweden | EGTX | |
|
ELARIS AG | Germany | ELS | |
|
Enervit | Italy | ENV | |
|
Enorama Pharma AB | Sweden | ERMA | |
|
Enzymatica AB | Sweden | ENZY | |
|
EQL Pharma AB | Sweden | EQL |